Andersson M M - OmicsDI

Show results for

Unknown (2406)
Transcriptomics (88)
Proteomics (76)
Genomics (18)
Metabolomics (7)
Models (1)

Organisms

Homo sapiens (106)
Mus musculus (31)
Rattus norvegicus (8)
Escherichia coli (5)
Gallus gallus (4)
Bacteria (3)
Bartonella grahamii (2)
Arabidopsis thaliana (2)
Apilactobacillus kunkeei (2)
Tuwongella immobilis (2)
Populus tremula (1)
Skeletonema marinoi (1)
Bartonella henselae (1)
Campylobacter jejuni (1)
Streptococcus pneumoniae (1)
Salmo salar (1)
Gadus morhua (1)
Malassezia sympodialis (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Candida albicans (1)
Chlorocebus aethiops (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Eukaryota (1)
Geobacillus kaustophilus (1)
Malassezia sympodialis ATCC 42132 (1)
Pseudomonas aeruginosa (1)
Rattus rattus (1)
Staphylococcus aureus (1)
Trypanosoma brucei (1)
Viruses (1)

Repository

biostudies-arrayexpress (91)
pride (72)
EGA (12)
MetaboLights (7)
ENA (3)
MassIVE (2)
BioModels (1)
jPOST (1)
PanoramaPublic (1)

Tissue

Cell culture (18)
Permanent cell line cell (6)
Endocrine pancreas (5)
Type B pancreatic cell (5)
C2C12 cell (4)
Epithelial cell (4)
Heart (4)
Liver (4)
Skeletal muscle cell line (4)
Spleen (4)
Bone marrow (2)
Epithelial cell of pancreas (2)
Muscle cell (2)
Neuroendocrine cell (2)
Pancreatic adenocarcinoma cell line (2)
Small intestine (2)
Bile duct (1)
Brain (1)
Breast (1)
Bronchoalveolar lavage (1)
Cell suspension culture (1)
Cervical cancer cell line (1)
Extrafusal muscle fiber (1)
Haploid cell (1)
Leg muscle (1)
Liposarcoma cell (1)
Lung (1)
Lymph node (1)
Lymphoblast (1)
Melanocyte (1)

Disease

Acute leukemia (2)
Breast cancer (2)
Small intestine neuroendocrine neoplasm (2)
Active ITP (1)
Rheumatoid arthritis (1)
Ovarian granulosa cell tumor, adult type (1)
Normal (1)
Alzheimer's disease (1)
Atopic dermatitis (1)
COVID-19 (1)
Cervix carcinoma (1)
Chronic obstructive pulmonary disease (1)
Cystic fibrosis (1)
Myxoid liposarcoma (1)
Osteoarthritis (1)
Ovarian cancer (1)
Pancreatic ductal adenocarcinoma (1)
Pancreatic ductal carcinoma (1)
Psoriasis (1)
Pulmonary fibrosis (1)
Skin melanoma (1)
Trypanosomiasis (1)

Technology Type

Mass Spectrometry (72)
Shotgun proteomics (44)
Bottom-up proteomics (17)
Data-dependent acquisition (12)
Affinity purification coupled with mass spectrometry proteomics (9)
SWATH MS (4)
Mass spectrometry (3)
NMR spectroscopy (3)
Gel-based experiment (3)
Data-independent acquisition (2)
Illumina CytoSNP, Illumina HumanOmni2.5, ILLUMINA, Illumina 450k, Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
Mass spectrometry imaging (1)

Instrument Platform

Illumina NovaSeq 6000 (10)
Illumina HiSeq 2500 (4)
Element AVITI (2)
Illumina HiSeq 2000 (2)
Bruker (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
BAS-1800 [FUJIFILM] (1)
DNA Microarray Scanner BA [Agilent Technologies] (1)
NextSeq 500 (1)
NanoACQUITY UPLC (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
6540 Q-TOF LC/MS (Agilent) (1)
Liquid Chromatography MS - alternating - hilic (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2026 (16)
2023 (15)
2010 (12)
2013 (11)
2025 (10)
2022 (10)
2020 (10)
2018 (10)
2021 (10)
2019 (9)
2024 (8)
2014 (8)
2012 (8)
2017 (6)
2011 (6)
2007 (6)
2016 (4)
2015 (4)
2008 (4)
2009 (3)
2006 (3)
2005 (1)
2004 (1)

CHEBI ID

CHEBI:15428 (3)
CHEBI:15891 (3)
CHEBI:17368 (3)
CHEBI:17596 (3)
CHEBI:17750 (3)
CHEBI:15354 (2)
CHEBI:15741 (2)
CHEBI:16027 (2)
CHEBI:16264 (2)
CHEBI:16449 (2)
CHEBI:16708 (2)
CHEBI:16761 (2)
CHEBI:17234 (2)
CHEBI:17345 (2)
CHEBI:17790 (2)
CHEBI:17895 (2)
CHEBI:18012 (2)
CHEBI:18132 (2)
CHEBI:18186 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:27266 (2)
CHEBI:29042 (2)
CHEBI:30887 (2)
CHEBI:32816 (2)
CHEBI:422 (2)
CHEBI:10782 (1)
CHEBI:1148 (1)
CHEBI:132542 (1)
CHEBI:137246 (1)

Metabolite Name

(S)-lactic acid (2)
ADP (2)
Betaine (2)
Choline (2)
Glycine (2)
Hypoxanthine (2)
Leucine (2)
Methanol (2)
Taurine (2)
Tyrosine (2)
(+/-)5-HEPE (1)
(+/-)5-HEPE / 5(S)-HEPE (1)
(R)-2-hydroxyglutaric acid (1)
(R)-carnitine (1)
(R)-malic acid (1)
(R)-mevalonic acid (1)
(S)-(-)-Perillyl alcohol (1)
1-Methylnicotinamide (1)
13(S)-HpOTrE (1)
17-Octadecynoic Acid (1)
2,5-Dimethylbenzaldehyde (1)
2-Hydroxycinnamic acid (1)
2-amino-2-deoxy-D-glucopyranose (1)
2-deoxy-D-glucose (1)
2-hydroxybutyric acid (1)
2-oxoadipic acid (1)
2-oxoglutaric acid (1)
3-(Butyl sulfinyl)-alanine (1)
3-hydroxykynurenine (1)
3-hydroxypyruvic acid (1)

IsPrivate

False (1)

First Public Date

2023 (1)
2021 (1)
2020 (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (46)
RNA-seq of coding RNA (16)
Methylation profiling by array (7)
Comparative genomic hybridization by array (6)
RNA-seq of coding RNA from single cells (3)
ChIP-chip by array (2)
Other (2)
ChIP-seq (2)
Unknown experiment type (1)
Human - One-color microarray (1)
Cell line - High-throughput sequencing (1)
Bisulfite-seq (1)
MicroRNA profiling by array (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2021 (272)
2022 (264)
2023 (235)
2025 (222)
2024 (200)
2020 (181)
2018 (177)
2019 (143)
2017 (131)
2016 (110)
2015 (95)
2014 (88)
2013 (65)
2011 (57)
2012 (55)
2010 (44)
2026 (41)
2008 (27)
2009 (26)
2007 (17)
2006 (14)
2004 (12)
2005 (11)
2003 (3)
2001 (3)
1998 (3)
2000 (1)

Lab affiliation

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. (5)
Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, SE-751 23 Uppsala, Sweden. (4)
Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France. (4)
Molecular Evolution, Department of Cell and Molecular Biology, Science for Life Laboratory, Biomedical Centre, Uppsala University, SE-751 24 Uppsala, Sweden (3)
Proteomics Core Facility, Sahlgrenska Academy, University of Gothenburg, Sweden (3)
Dept. Oncology Pathology, Science for Life Laboratory, Karolinska Institutet, Sweden (2)
Div. Clinical Protein Science & Imaging, Dept. of Clinical Sciences (Lund) and Dept. of Biomedical Engineering, Lund University, Lund, Sweden (2)
ICM, Molecular Evolution, Uppsala University (2)
Mass Spectrometry Facility, Max Perutz Labs Vienna, University of Vienna, Vienna Biocenter, Dr.-Bohr-Gasse 7, 1030 Vienna (2)
Aarhus University Institute of Molecular Biology and Genetics Universitetsbyen 81 8000 Aarhus Denmark (1)
AstraZeneca (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
Cancer proteomics, Oncology-Pathology department, Karolinska Institutet (1)
College of Science and Mathematics, Kennesaw State University, USA (1)
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden (1)
Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, 75123, Uppsala, Sweden (1)
Department of Medical Biochemistry and Microbiology, Uppsala University, PO Box 582, SE-751 23, Uppsala, Sweden (1)
Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden (1)
Department of Pharmaceutical Sciences University of Maryland Baltimore, Maryland USA (1)
Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden. (1)
Department of Respiratory Medicine and Allergology, Faculty of Medicine, Lund University, Sweden (1)
Department of Rheumatology and Inflammation research, Sahlgrenska academy, Gothenburg University, Gothenburg, Sweden (1)
Department of Surgery. Clincal Sciences Lund. Lund University (1)
Depratment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. (1)
Dept. Oncology Pathology, Karolinska Institutet and Scilifelab, Stockholm, Sweden (1)
Derpatment of Medical Biochemistry, Uppsala University, Uppsala, Sweden. (1)
Div. Clinical Protein Science & Imaging Dept. of Clinical Sciences (Lund) and Dept. of Biomedical Engineering Lund University (1)
Division of Infection Medicine, BMC Faculty of Medicine Lund University Lund, Sweden (1)
Division of Molecular Hematology, Department of Laboratory Medicine, Lund University (1)
Functional Proteomics Unit Chronic Disease Programme Instituto de Salud Carlos III (1)

Previous page
1 / 260
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 260
Next page

Sort by:

Relevance

Page size

Collateral sensitivity constrains resistance evolution of the CTX-M-15 β-lactamase.

Not available

S-EPMC6365502 | biostudies-literature

Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.

Not available

S-EPMC5582836 | biostudies-literature

A simple repeat polymorphism in the MITF-M promoter is a key regulator of white spotting in dogs.

Not available

S-EPMC4130573 | biostudies-literature

The Matrix-M™ adjuvant: A critical component of vaccines for the 21^st century.

Not available

S-EPMC10158541 | biostudies-literature

Stomach cancer risk after treatment for hodgkin lymphoma.

Not available

S-EPMC3770865 | biostudies-literature

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization.

Not available

S-EPMC12325594 | biostudies-literature

Prolonged Outbreak of Multidrug-Resistant Shigella sonnei Harboring bla_CTX-M-27 in Victoria, Australia.

Not available

S-EPMC7674062 | biostudies-literature

Identifying metabolic alterations associated with coral growth anomalies using 1H NMR metabolomics

Coral growth anomalies (GAs) are tumor-like protrusions that are detrimental to coral health, impacting both the coral skeleton and soft tissues. These lesions are increasingly found throughout the tropics and are commonly associated with high human population density, yet little is known about the ...

2021-06-15 | MTBLS2424 | MetaboLights

The fat cell epigenetic signature in post-obese women is characterized by global hypomethylation and differential DNA methylation of adipogenesis genes

Background/Objectives: Obese subjects have increased number of enlarged fat cells which are reduced in size but not number in post-obesity. We performed DNA methylation profiling in fat cells with the aim of identifying differentially methylated DNA sites (DMS) linked to adipose hyperplasia (many sm...

ORGANISM(S): Homo sapiens

2015-05-06 | E-GEOD-58622 | biostudies-arrayexpress

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals.

Not available

S-EPMC3070784 | biostudies-literature

Previous page
1 / 260
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 260
Next page

Sort by:

Relevance

Page size

2596 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets